Role of cystatin C in renal damage and the optimum cut-off point of renal damage among patients with type 2 diabetes mellitus

Experimental and Therapeutic Medicine

Volumn 8, Issue 3, 2014, Pages 887-892

  Rao, Xiaopang ^a   Wan, Meiyan ^b   Qiu, Caixia ^a   Jiang, Chongcai ^a  

^a Chengyang People's Hospital   (China)

^b QINGDAO MUNICIPAL HOSPITAL   (China)

Author keywords

Cut off point; Renal impairment; Serum cystatin C; Type 2 diabetes mellitus; Urinary cystatin C

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; CYSTATIN C; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE DURATION; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HUMAN; IMMUNOASSAY; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; NEPHELOMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALUE; QUESTIONNAIRE; RELIABILITY; RISK; SENSITIVITY AND SPECIFICITY; URINE LEVEL;

EID: 84904398777     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1815     Document Type: Article

References (23)

1. Wild S, Roglic G, Green A, Sicree R and King H: Global prevalence of diabetes: estimates for the year 2000 and projection for 2030. Diabetes Care 27: 1047-1053, 2004.
2. Zhang J and Zhang JQ: The mechanism of transforming growth factor beta and diabetic nephropathy. Chinese Journal of Nephrology 13: 187-189, 1997 (In Chinese).
3. Chen XM: Tubulointerstitial damage in glomerular diseases progress. Chinese Journal of Nephrology 18: 146-147, 2002 (In Chinese).
4. Valk EJ, Bruijn JA and Bajema IM: Diabetic nephropathy in human: pathologic diversity. Curr Opin Nephrol Hypertens 20: 285-289, 2011.
5. Shao C, Wang Y and Gao Y: Applications of urinary proteomics in biomarker discovery. Sci China Life Sci 54: 409-417, 2011.
6. Keller CK, Bergis KH, Fliser D and Ritz E: Renal finding in patients with short-term type 2 diabetes. J Am Soc Nephrol 7: 2627-2635, 1996.
7. Liu Z and Li L: Pathogenesis of diabetic nephropathy. Chinese Journal of Nephrology 15: 120-122, 1999.
8. Pagtalunan ME, Miller PL, Nelson RG, et al: Glomerular structure in Pima Indians with type II diabetes mellitus (Abstract). J Am Soc Nephrol 5: 381-382, 1994.
9. Lu ZY and Zhong NS (eds): Internal Medicine. 13th edition. People's Health Publishing House, Beijing, p549, 2007.
10. Negrean V, Suciu I, Sâmpelean D and Cozma A: Rheological changes in diabetic microangiopathy. Rom J Intern Med 42: 407-413, 2004.
11. Levey AS, Greene T, Kusek JW and Beck GJ: Simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 11: A826-A828, 2000.
12. Trivedi HS, Pang MM, Campbell A and Saab P: Slowing the progression of chronic renal failure: economic benefits and patients' perspective. Am J Kidney Dis 39: 721-729, 2002.
13. Grubb A1, Nyman U, Björk J, Lindström V, Rippe B, Sterner G and Christensson A: Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. Clin Chem 51: 1420-1431, 2005.
14. Tarif N, Alwalkeel JS, Mitwalli AH, et al: Serum cystatin C as a marker of renal function in patients with acute renal failure. Saudi J Kidney Dis Transpl 19: 918-923, 2008.
15. Jiborn T, Albrahamson M, Wallin H, et al: Cystatin C is highly expressed in the human male reproductive system. J Androl 25: 564-572, 2004.
16. Ozden TA, Tekerek H, Baş F and Darendeliler F: Effect of hypo-and euthyroid status on serum cystatin C levels. J Clin Res Pediatr Endocrinol 2: 155-158, 2010.
17. Cordeiro VF, Pinheiro DC, Silva GB Jr, et al: Comparative study of cystatin C and serum creatinine in the estimative of glomerular filtration rate in children. Clin Chim Acta 391: 46-50, 2008.
18. Pucci L, Triscornia S, Lucchesi D, et al: Cystatin C and estimates of renal function searching for a better measure of kidney function in diabetic patient. Clin Chem 53: 480-488, 2007.
19. Rigalleau V, Beauvieux MC, Le Moigne F, et al: Cystatin C improves the diagnosis and stratification of chronic kidney disease, and the estimation of glomerular filtration rate in diabetes. Diabetes Metab 34: 482-489, 2008.
20. Willems D, Wolff F, Mekahli F and Gillet C: Cystatin C for early detection of renal impairment in diabetes. Clin Biochem 42: 108-110, 2009.
21. Sahakyan K, Lee KE, Shankar A and Klein R: Serum cystatin C and the incidence of type 2 diabetes mellitus. Diabetolgia 54: 1335-1340, 2011.
22. Jacobsson B, Lignelid H and Bergerbeim US: Transthyretin and cystatin C are catabolized in proximal tubular endothelial cells and the proteins are notuseful as marker for renal cel carcinomas.Histopathology 26: 559-564, 1995.
23. Tong N and Liang J: Diabetic renal tubule lesion. Foreign Medical Department of Internal Medicine 28: 25-28, 2001 (In Chinese).